| A white-box machine learning approach for revealing antibiotic mechanisms of action JH Yang, SN Wright, M Hamblin, D McCloskey, MA Alcantar, ... Cell 177 (6), 1649-1661. e9, 2019 | 260 | 2019 |
| A CRISPR–Cas9-based gene drive platform for genetic interaction analysis in Candida albicans RS Shapiro, A Chavez, CBM Porter, M Hamblin, CS Kaas, JE DiCarlo, ... Nature microbiology 3 (1), 73-82, 2018 | 145 | 2018 |
| Understanding and sensitizing density-dependent persistence to quinolone antibiotics A Gutierrez, S Jain, P Bhargava, M Hamblin, MA Lobritz, JJ Collins Molecular Cell 68 (6), 1147-1154. e3, 2017 | 138 | 2017 |
| Salmonella-driven polarization of granuloma macrophages antagonizes TNF-mediated pathogen restriction during persistent infection THM Pham, SM Brewer, T Thurston, LM Massis, J Honeycutt, K Lugo, ... Cell host & microbe 27 (1), 54-67. e5, 2020 | 95 | 2020 |
| One species, different diseases: the unique molecular mechanisms that underlie the pathogenesis of typhoidal Salmonella infections BX Wang, DSC Butler, M Hamblin, DM Monack Current Opinion in Microbiology 72, 102262, 2023 | 12 | 2023 |
| Draft genome sequence of the shellfish larval probiotic Bacillus pumilus RI06-95 M Hamblin, E Spinard, M Gomez-Chiarri, DR Nelson, DC Rowley Genome Announcements 3 (5), 10.1128/genomea. 00858-15, 2015 | 4 | 2015 |
| Salmonella enterica serovar Typhi uses two type 3 secretion systems to replicate in human macrophages and colonize humanized mice M Hamblin, R Schade, R Narasimhan, DM Monack Mbio 14 (4), e01137-23, 2023 | 1 | 2023 |
| Combating infectious diseases in aquaculture with an original probiotic product M Hamblin, S Sohn, CA Dao, M Gomez-Chiarri, DR Nelson, D Worthen, ... | 1 | 2015 |
| Identifying Virulence Factors that Enable Salmonella Typhi Replication in Human Macrophages M Hamblin Stanford University, 2023 | | 2023 |
| KatG catalase deficiency confers bedaquiline hyper-susceptibility to isoniazid resistant Mycobacterium tuberculosis N Ofori-Anyinam, M Hamblin, ML Coldren, B Li, G Mereddy, M Shaikh, ... bioRxiv, 2023.10. 17.562707, 2023 | | 2023 |
| Combining metabolic stimulation and amino acids to sensitize tolerant bacteria to antibiotics S Bening, M Hamblin, I Andrews, A Lopatkin, J Collins US Patent App. 17/425,438, 2022 | | 2022 |
